DATE
04/11/2022 - 06/11/2022
TOTAL VIEWS
10970
Google Calendar
ICal
Outlook
Welcome
Videos On Demand
Scientific Program
Contact
e-Certificate
Sponsors
Videos On Demand
04/11/2022
11.30-13.30 The Most Impactful Antithrombotic Trials in 2021-2022
13.30-14.30 Meet the Experts: From ACS to chronic coronary artery disease. The transition period
15.30-16.30 Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
16.30-17.00 Antithrombotic Therapy in cardiac Operations
17.30-19.00 Plenary Session. Stroke therapeutics: an update
19.00-20.00 Plenary Session. Cardiovascular complications in cancer patients
20.20-20.45 Official Opening of ALPIC 2022
20.45-21.10 Opening Lecture
05/11/2022
08.30-10.00 Atrial fibrillation and the Prothrombotic state: New insights for 2021-2022
10.30-11.30 How to Treat Session. Practical Guidance in Antithrombotic Therapy
11.30-12.00 Satellite Lecture
12.00-13.00 Meet the Experts session: Unaddressed issues in Thrombosis and Haemostasis
13.00-14.30 Clinical Seminar. Management of acute ischemic stroke
15.30-17.00 Meet the Experts. Management of thrombosis at unusual sites. Which antithrombotic and for how long?
17.00-17.30 Keynote Lecture
18.00-20.00 Plenary Session. Cardiometabolic Risk Factors and Thrombosis. From Pathophysiology to Therapy
20.00-21.00 Keynote Lectures. Recent guidelines on antithrombotic management
06/11/2022
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
11.30-13.15 Challenging the risk and management of venous thromboembolism in Women
04/11/2022
11.30-13.30 The Most Impactful Antithrombotic Trials in 2021-2022
HEP-COVID | Matilda Florentin
137 Views
MICHELLE, Μελέτη INVICTUS | Theodora Babali
131 Views
REMAP-CAP, ACTIV-4a, and ATTACC | Georgia Kaiafa
135 Views
MASTER DAPT | Dimitrios Nikas
133 Views
ADAPT-TAVR | Georgios Almpanis
124 Views
STOPDAPT-2 ACS | Dimitrios Alexopoulos
125 Views
IMPROVE VTE (Hospitalized medically ill patients) | Ioannis Koulas
128 Views
PACIFIC Program (AF, AMI, STROKE) | John Goudevenos
136 Views
13.30-14.30 Meet the Experts: From ACS to chronic coronary artery disease. The transition period
P2Y12 Μonotherapy following PCI. An alternative approach | Dimitrios Alexopoulos
180 Views
Dual anti platelet therapy duration? Very short or very long? | John Kanakakis
139 Views
Very low dose of rivaroxaban. It is time for a new era in antithrombotic treatment? | Christos Katsouras
127 Views
The bleeding risk. The true game changer? | Georgios Almpanis
131 Views
15.30-16.30 Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
Interactive Workshop. Real-World Data on Thrombosis Incidence and Treatment in Countries Affiliated to EMLTD
147 Views
16.30-17.00 Antithrombotic Therapy in cardiac Operations
Antithrombotic therapy of patients undergoing noncardiac operations according to 2022 ESC guidelines | Michail Botis
176 Views
Antithrombotic Therapy in Patients Undergoing Transcatheter interventions for Structural Heart Disease | Gregoris Pattakos
127 Views
17.30-19.00 Plenary Session. Stroke therapeutics: an update
Tenecteplase vs alteplase for iv thrombolysis in Acute Ischemic Stroke Georgios Tsivgoulis
141 Views
Combination of antiplatelets and anticoagulants for secondary stroke prevention | Lina Palaiodimou
131 Views
Inhibition of factor XI: a new therapeutic horizon for secondary stroke prevention | John Ellul
135 Views
Inflammation: a new therapeutic target for atherothrombotic stroke prevention | Odysseas Kargiotis
124 Views
19.00-20.00 Plenary Session. Cardiovascular complications in cancer patients
Evolving data on cardiovascular complications in cancer | Nikos Tsoukalas
127 Views
Venous Thromboembolism and Risk Stratification in Hematological Malignancies Georgia Kaiafa
125 Views
Cardiotoxicity of Cardiovascular drugs. Focus on antithrombotics | Alexandros Tselepis
121 Views
Optimizing antithrombotic therapy for atrial fibrillation in cancer Georgios Andrikopoulos
129 Views
20.20-20.45 Official Opening of ALPIC 2022
Official Opening of ALPIC 2022
130 Views
20.45-21.10 Opening Lecture
Deep Learning and Artificial Intelligence | Panos Vardas
141 Views
05/11/2022
08.30-10.00 Atrial fibrillation and the Prothrombotic state: New insights for 2021-2022
Prothrombotic conditions and Stroke | Georgia Kaiafa
123 Views
Stroke risk assessment in AF: Simplicity and practicality matter | Dimitrios Richter
124 Views
Bleeding risk assessment: Its appropriate use and inappropriate mis-use | Vitorio Pengo
125 Views
Biomarkers for risk stratification in AF Stylianos Tzeis
129 Views
10.30-11.30 How to Treat Session. Practical Guidance in Antithrombotic Therapy
Α 35 year-old woman diagnosed with unprovoked DVT. How far should we extend the antithrombotic treatment? | Kalliroi Kalantzi
131 Views
A 72 year old patient with colonic cancer and pulmonary embolism | Stavroula Tsiara
131 Views
A 70 Years Old Patient with Atrial Fibrillation on DOAC and Melena | Athanasios Pipilis
132 Views
Stroke management in COVID-19 patients in the Internal Medicine Unit of a Reference Hospital |Christos Savopoulos
128 Views
11.30-12.00 Satellite Lecture
PCI/ACS and Atrial Fibrillation - Optimal Antithrombotic treatment | John Kanakakis
145 Views
12.00-13.00 Meet the Experts session: Unaddressed issues in Thrombosis and Haemostasis
Diagnostic and therapeutic approach to a bleeding patient with normal routine coagulation tests | Despina Adamidou
180 Views
13.00-14.30 Clinical Seminar. Management of acute ischemic stroke
Dissolve thrombus. What to expect? | Dimitris Sagris
120 Views
Retrieving emboli. Where do we stand? | Panagiotis Papanagiotou
125 Views
15.30-17.00 Meet the Experts. Management of thrombosis at unusual sites. Which antithrombotic and for how long?
Splanchnic thrombosis | Georgios Glantzounis
126 Views
Cerebral sinus thrombosis | Konstantinos Vemmos
125 Views
Upper extremity thrombosis | Athanasios Gianoukas
127 Views
17.00-17.30 Keynote Lecture
Remote monitoring of cardiometabolic disease patients | Apostolos Pappas
124 Views
18.00-20.00 Plenary Session. Cardiometabolic Risk Factors and Thrombosis. From Pathophysiology to Therapy
Major dietary patterns and atherothrombotic disease; from epidemiology to clinical practice | Demosthenes Panagiotakos
122 Views
Postprandial dysmetabolism - A daily stressor of platelets? | Tzortzis Nomikos
123 Views
"GLP-1 receptor agonists and stroke primary prevention" | Theodosios Philippatos
122 Views
Metabolic Syndrome – Diabetes Mellitus and the risk of LEAD | Nikolaos Tentolouris
122 Views
Lp(a) and Thromboembolic Risk. Present and future | Alexandros Tselepis
104 Views
Reduction of ischemic events with the use of PCSK9 inhibitors. Results from recent clinical trials | Evangelos Liberopoulos
96 Views
20.00-21.00 Keynote Lectures. Recent guidelines on antithrombotic management
2022 ACCP perioperative antithrombotic management guidelines | James Douketis
116 Views
2002 ISTH COVID anticoagulation guidelines | James Douketis - Alex Spyropoulos
110 Views
06/11/2022
09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels
Hypertension and ischemic stroke: from pathophysiology to effective management | Nikolaos Kakaletsis
129 Views
Lp (a) and stroke: potential relationship, attributable risk and management | Matilda Florentin
107 Views
PFO: to close or not to close? | Paraskevi Savvari
108 Views
CAS vs. CAE: Pros and cons | Dimitrios Nikas
109 Views
Thrombophilia and stroke: an innocent bystander? | Georgia Kaiafa
112 Views
11.30-13.15 Challenging the risk and management of venous thromboembolism in Women
Hormonal therapy and risk of thrombosis | Ploutarchos Tzoulis
110 Views
Special issues regarding the Prophylaxis and Therapy of VTE in women of all ages | Eleftheria Lefkou
117 Views
Post-thrombotic syndrome in women | Konstantinos Konstantinides
111 Views
Thrombosis and Placenta | Vasileios Papadopoulos
109 Views
Scientific Program
×
.mp4_snapshot_00.01.282.jpg)
